Cocrystal Pharma Inc (COCP) is a Healthcare · Biotechnology company listed on NASDAQ. Price $1.15 (+0.91%), Market cap $0.02B, 52-week low–high $0.86 ~ $1.94.
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases in the United States. The company employs structure-based technologies to create antiviral drugs including influenza virus, norovirus, coronaviruses, such as SARS-CoV-2 and MERS-CoV, as well as respiratory virus infections, and hepatitis C virus (HCV) infections. The company develops CC-42344, a novel PB2 inhibitor, which is in phase 2a clinical trial, as a potential treatment for pandemic and seasonal influenza A; and the inhaled CC-42344 for the potential prophylactic treatment of pandemic and seasonal influenza infections.
Financial statements, price targets, institutional (13F) holdings and related news for Cocrystal Pharma Inc are updated in real time on BlackAll Trade.
Cocrystal Pharma Inc trades at $1.15 (+0.91%). Real-time quotes and charts are available on BlackAll Trade.
Cocrystal Pharma Inc has a market cap of about $0.02B.
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases in the United States. The compan